Cell therapy for liver diseases: current medicine and future promises

References

• Fischbach GD, Fischbach RL. Stem cells: science, policy, and ethics. J Clin Invest 2004;114(10):1364-70
   PubMed Web of Science ®Google Scholar
• Zhao Q, Ren H, Zhu D, Han Z. Stem/progenitor cells in liver injury repair and regeneration. Biol Cell 2009;101(10):557-71
   PubMed Web of Science ®Google Scholar
• Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell 2004;116(5):639-48
   PubMed Web of Science ®Google Scholar
• Fortier LA. Stem cells: classifications, controversies, and clinical applications. Vet Surg 2005;34(5):415-23
   PubMed Web of Science ®Google Scholar
• Marone M, De Ritis D, Bonanno G, et al. Cell cycle regulation in human hematopoietic stem cells: from isolation to activation. Leuk Lymphoma 2002;43(3):493-501
   PubMed Web of Science ®Google Scholar
• Young HE, Black ACJr. Adult stem cells. Anat Rec A Discov Mol Cell Evol Biol 2004;276(1):75-102
   PubMedGoogle Scholar
• Smith AG. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 2001;17(1):435-62
   PubMedGoogle Scholar
• International Stem Cell Initiative. Adewumi O, Aflatoonian B, Ahrlund-Richter L, et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007;25(7):803-16
   PubMed Web of Science ®Google Scholar
• Draper JS, Pigott C, Thomson JA, Andrews PW. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat 2002;200(3):249-58
   PubMed Web of Science ®Google Scholar
• De Wert G, Mummery C. Human embryonic stem cells: research, ethics and policy. Hum Reprod 2003;18(4):672-82
   PubMed Web of Science ®Google Scholar
• Panteleev A, Vorob’ev I. [Expression of early hematopoietic markers in cord blood and mobilized blood]. Tsitologiia 2011;54(10):774-82
   Google Scholar
• Martinez-Agosto JA, Mikkola HK, Hartenstein V, Banerjee U. The hematopoietic stem cell and its niche: a comparative view. Genes Dev 2007;21(23):3044-60
   PubMed Web of Science ®Google Scholar
• Satija NK, Singh VK, Verma YK, et al. Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med 2009;13(11-12):4385-402
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8(4):315-17
   PubMed Web of Science ®Google Scholar
• Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275(5302):964-6
   PubMed Web of Science ®Google Scholar
• Kaushal S, Amiel GE, Guleserian KJ, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001;7(9):1035-40
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126(4):663-76
   PubMed Web of Science ®Google Scholar
• Quirici N, Soligo D, Caneva L, et al. Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells. Br J Haematol 2001;115(1):186-94
   PubMed Web of Science ®Google Scholar
• Tsao M-S, Smith JD, Nelson KG, et al. A diploid epithelial cell line from normal adult rat liver with phenotypic properties of oval cells. Exp Cell Res 1984;154(4):38-52
   PubMedGoogle Scholar
• Kisseleva T, Gigante E, Brenner DA. Recent advances in liver stem cell therapy. Curr Opin Gastroenterol 2010;26(4):395-402
   PubMed Web of Science ®Google Scholar
• Khurana S, Mukhopadhyay A. Characterization of the potential subpopulation of bone marrow cells involved in the repair of injured liver tissue. Stem Cells 2007;25(6):1439-47
   PubMed Web of Science ®Google Scholar
• Jung YJ, Ryu KH, Cho SJ, et al. Syngeneic bone marrow cells restore hepatic function in carbon tetrachloride-induced mouse liver injury. Stem Cells Dev 2006;15(5):687-95
   PubMed Web of Science ®Google Scholar
• Kollet O, Shivtiel S, Chen YQ, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003;112(2):160-9
   PubMed Web of Science ®Google Scholar
• Grompe M. The role of bone marrow stem cells in liver regeneration. Semin Liver Dis 2003;23(4):363-72
   PubMed Web of Science ®Google Scholar
• Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6(11):1229-34
   PubMed Web of Science ®Google Scholar
• Camargo FD, Finegold M, Goodell MA. Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners. J Clin Invest 2004;113(9):1266-70
   PubMed Web of Science ®Google Scholar
• Tsolaki E, Athanasiou E, Gounari E, et al. Hematopoietic stem cells and liver regeneration: differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury. Blood Cells Mol Dis 2014;53(3):124-32
   PubMed Web of Science ®Google Scholar
• Quante M, Wang TC. Stem cells in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2009;6(12):724-37
   PubMed Web of Science ®Google Scholar
• Ivanova NB, Dimos JT, Schaniel C, et al. A stem cell molecular signature. Science 2002;298(5593):601-4
   PubMed Web of Science ®Google Scholar
• Avital I, Inderbitzin D, Aoki T, et al. Isolation, characterization, and transplantation of bone marrow-derived hepatocyte stem cells. Biochem Biophys Res Commun 2001;288(1):156-64
   PubMed Web of Science ®Google Scholar
• Farber E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3’-methyl-4-dimethylaminoazobenzene. Cancer Res 1956;16(2):142-8
   PubMed Web of Science ®Google Scholar
• Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999;284(5417):1168-70
   PubMed Web of Science ®Google Scholar
• Mitaka T. Hepatic stem cells: from bone marrow cells to hepatocytes. Biochem Biophys Res Commun 2001;281(1):1-5
   PubMed Web of Science ®Google Scholar
• Yasui O, Miura N, Terada K, et al. Isolation of oval cells from Long-Evans Cinnamon rats and their transformation into hepatocytes in vivo in the rat liver. Hepatology 1997;25(2):329-34
   PubMed Web of Science ®Google Scholar
• Turner RA, Wauthier E, Lozoya O, et al. Successful transplantation of human hepatic stem cells with restricted localization to liver using hyaluronan grafts. Hepatology 2013;57(2):775-84
   PubMed Web of Science ®Google Scholar
• Herrera MB, Fonsato V, Bruno S, et al. Human liver stem cells improve liver injury in a model of fulminant liver failure. Hepatology 2013;57(1):311-19
   PubMed Web of Science ®Google Scholar
• Lin H, Xu R, Zhang Z, et al. Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases. Cell Mol Immunol 2010;8(1):19-22
   PubMed Web of Science ®Google Scholar
• Usunier B, Benderitter M, Tamarat R, Chapel A. Management of fibrosis: the mesenchymal stromal cells breakthrough. Stem Cells Int 2014;2014:340257
   PubMedGoogle Scholar
• Lee KD, Kuo TK, Whang-Peng J, et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004;40(6):1275-84
   PubMed Web of Science ®Google Scholar
• Cho KA, Ju SY, Cho SJ, et al. Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow. Cell Biol Int 2009;33(7):772-7
   PubMed Web of Science ®Google Scholar
• Aurich H, Sgodda M, Kaltwasser P, et al. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 2009;58(4):570-81
   PubMed Web of Science ®Google Scholar
• Kuo TK, Hung SP, Chuang CH, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008;134(7):2111
   PubMed Web of Science ®Google Scholar
• Mouiseddine M, François S, Souidi M, Chapel A. Intravenous human mesenchymal stem cells transplantation in NOD/SCID mice preserve liver integrity of irradiation damage. Methods Mol Biol 2012;826:179-88
   PubMedGoogle Scholar
• Chen YT, Sun CK, Lin YC, et al. Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med 2011;9(1):51-7
   PubMedGoogle Scholar
• Francois S, Mouiseddine M, Allenet-Lepage B, et al. Human mesenchymal stem cells provide protection against radiation-induced liver injury by antioxidative process, vasculature protection, hepatocyte differentiation, and trophic effects. Biomed Res Int 2013;2013:151679
   PubMedGoogle Scholar
• Zuk P. Adipose-derived stem cells in tissue regeneration: a review. ISRN Stem Cells 2013;2013:713959
   Google Scholar
• Salgado AJ, Reis RL, Sousa NJ, Gimble JM. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 2010;5(2):103-10
   PubMed Web of Science ®Google Scholar
• Parekkadan B, van Poll D, Megeed Z, et al. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun 2007;363(2):247-52
   PubMed Web of Science ®Google Scholar
• Yuan S, Jiang T, Sun L, et al. The role of bone marrow mesenchymal stem cells in the treatment of acute liver failure. Biomed Res Int 2013;2013:251846
   PubMed Web of Science ®Google Scholar
• Meier RP, Mahou R, Morel P, et al. Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice. J Hepatol 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Chamberlain J, Yamagami T, Colletti E, et al. Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep. Hepatology 2007;46(6):1935-45
   PubMed Web of Science ®Google Scholar
• Chen L, Tredget EE, Wu PY, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008;3(4):e1886
   PubMed Web of Science ®Google Scholar
• Ortiz LA, Dutreil M, Fattman C, et al. Interleukin 1 receptor antagonist mediates the anti-inflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 2007;104(26):11002-7
   PubMed Web of Science ®Google Scholar
• Ayatollahi M, Hesami Z, Jamshidzadeh A, Gramizadeh B. Antioxidant effects of bone marrow mesenchymal stem cell against carbon tetrachloride-induced oxidative damage in rat livers. Int J Organ Transplant Med 2014;5(4):166
   PubMedGoogle Scholar
• Lopatina T, Mazzeo A, Bruno S, et al. The angiogenic potential of adipose mesenchymal stem cell-derived extracellular vesicles is modulated by basic fibroblast growth Factor. J Stem Cell Res Ther 2014;4(245):2
   Google Scholar
• Li C, Kong Y, Wang H, et al. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol 2009;50(6):1174-83
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang P, Sun T, et al. miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol 2013;15(3):284-94
   PubMed Web of Science ®Google Scholar
• Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449(7162):557-63
   PubMed Web of Science ®Google Scholar
• Mognetti B, La Montagna G, Perrelli MG, et al. Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell-derived factor-1alpha. J Cell Mol Med 2013;17(2):287-92
   PubMed Web of Science ®Google Scholar
• Ohashi K, Park F, Kay MA. Hepatocyte transplantation: clinical and experimental application. J Mol Med (Berl) 2001;79(11):617-30
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Ito M, Nakamura J, et al. Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology 2000;31(4):851-7
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Quinn G, Asari A, et al. Differentiation of embryonic stem cells into hepatocytes: biological functions and therapeutic application. Hepatology 2003;37(5):983-93
   PubMed Web of Science ®Google Scholar
• Kuai XL, Cong XQ, Li XL, Xiao SD. Generation of hepatocytes from cultured mouse embryonic stem cells. Liver Transpl 2003;9(10):1094-9
   PubMed Web of Science ®Google Scholar
• Teratani T, Yamamoto H, Aoyagi K, et al. Direct hepatic fate specification from mouse embryonic stem cells. Hepatology 2005;41(4):836-46
   PubMed Web of Science ®Google Scholar
• Wang Z, Lu H, Wang YC, et al. Human embryonic stem cells and liver diseases: from basic research to future clinical application. J Dig Dis 2008;9(1):14-19
   PubMed Web of Science ®Google Scholar
• Yamada T, Yoshikawa M, Kanda S, et al. In Vitro differentiation of embryonic stem cells into hepatocyte-like cells identified by cellular uptake of indocyanine green. Stem Cells 2002;20(2):146-54
   PubMed Web of Science ®Google Scholar
• Taniguchi E, Kin M, Torimura T, et al. Endothelial progenitor cell transplantation improves the survival following liver injury in mice. Gastroenterology 2006;130(2):521-31
   PubMed Web of Science ®Google Scholar
• Nakamura T, Torimura T, Sakamoto M, et al. Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. Gastroenterology 2007;133(1):91-107.e1
   PubMed Web of Science ®Google Scholar
• Sancho-Bru P, Roelandt P, Narain N, et al. Directed differentiation of murine-induced pluripotent stem cells to functional hepatocyte-like cells. J Hepatol 2011;54(1):98-107
   PubMed Web of Science ®Google Scholar
• Li W, Wang D, Qin J, et al. Generation of functional hepatocytes from mouse induced pluripotent stem cells. J Cell Physiol 2010;222(3):492-501
   PubMed Web of Science ®Google Scholar
• Song Z, Cai J, Liu Y, et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009;19(11):1233-42
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yin X, Qin H, et al. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 2008;3(5):475-9
   PubMed Web of Science ®Google Scholar
• Puppi J, Strom SC, Hughes RD, et al. Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant 2012;21(1):1-10
   PubMed Web of Science ®Google Scholar
• Zhu S, Rezvani M, Harbell J, et al. Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature 2014;508(7494):93-7
   PubMed Web of Science ®Google Scholar
• Terai S, Ishikawa T, Omori K, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006;24(10):2292-8
   PubMed Web of Science ®Google Scholar
• Körbling M, Katz RL, Khanna A, et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med 2002;346(10):738-46
   PubMed Web of Science ®Google Scholar
• Gordon MY, Levicar N, Pai M, et al. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 2006;24(7):1822-30
   PubMed Web of Science ®Google Scholar
• am Esch JS2nd, Knoefel WT, Klein M, et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005;23(4):463-70
   PubMed Web of Science ®Google Scholar
• Fürst G, Schulte am Esch J, Poll LW, et al. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience. Radiology 2007;243(1):171-9
   PubMed Web of Science ®Google Scholar
• Levicar N, Pai M, Habib NA, et al. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease. Cell Prolif 2008;41(Suppl 1):115-25
   PubMed Web of Science ®Google Scholar
• Lorenzini S, Isidori A, Catani L, et al. Stem cell mobilization and collection in patients with liver cirrhosis. Aliment Pharmacol Ther 2008;27(10):932-9
   PubMed Web of Science ®Google Scholar
• Huang XL, Luo L, Luo LY, et al. Clinical outcome of autologous hematopoietic stem cell infusion via hepatic artery or portal vein in patients with end-stage liver diseases. Chin Med Sci J 2014;29(1):15-22
   PubMedGoogle Scholar
• Kharaziha P, Hellström PM, Noorinayer B, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 2009;21(10):1199-205
   PubMed Web of Science ®Google Scholar
• Couto BG, Goldenberg RC, da Fonseca LM, et al. Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study. Liver Int 2011;31(3):391-400
   PubMed Web of Science ®Google Scholar
• Nikeghbalian S, Pournasr B, Aghdami N, et al. Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis. Arch Iran Med 2011;14(1):12-17
   PubMed Web of Science ®Google Scholar
• Mohamadnejad M, Ashrafi M, Alimoghaddam K, et al. Surveillance for hepatocellular carcinoma after autologous stem cell transplantation in cirrhosis. Middle East J Dig Dis 2012;4(3):145-9
   PubMedGoogle Scholar
• Zhang Z, Lin H, Shi M, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol 2012;27(Suppl 2):112-20
   PubMed Web of Science ®Google Scholar
• Available from: https://clinicaltrials.gov/ct2/show/NCT00913289
   Google Scholar
• Khan AA, Shaik MV, Parveen N, et al. Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. Cell Transplant 2010;19(4):409-18
   PubMed Web of Science ®Google Scholar
• Khan AA, Parveen N, Mahaboob VS, et al. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study. Transplant Proc 2008;40(4):1140-4
   PubMed Web of Science ®Google Scholar
• Pai M, Zacharoulis D, Milicevic MN, et al. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 2008;103(8):1952-8
   PubMed Web of Science ®Google Scholar
• Lyra AC, Soares MB, da Silva LF, et al. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol 2010;22(1):33-42
   PubMed Web of Science ®Google Scholar
• Salama H, Zekri AR, Bahnassy AA, et al. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol 2010;16(42):5297
   PubMed Web of Science ®Google Scholar
• Jun G, Qinglian C, Ling D, et al. Clinical study of the treatment with human umbilical cord mesenchymal stem cell transplantation via hepatic artery for decompensated cirrhosis. Mod J Integr Tradit Chine West Med 2012;5:006
   Google Scholar
• Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 2007;10(4):459-66
   PubMed Web of Science ®Google Scholar
• Available from: http://clinicaltrials.gov/show/NCT01013194?displayxml=true
   Google Scholar
• Kaji EH, Leiden JM. Gene and stem cell therapies. JAMA 2001;285(5):545-50
   PubMed Web of Science ®Google Scholar